Decentralized Trials STREAM

  1. Harness The Power Of eCOA In Your Next Trial

    In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.

  2. Patient First Solutions For Oncology 2/14/2023

    Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.

  3. Leveraging DHTs To Improve Data Collection And Analysis 2/25/2025

    How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?

  4. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

  5. Medable Total Consent: The Future Of Informed Consent 2/14/2023

    With Total Consent, Medable is transforming the consenting process – harmonizing it into one simple-to-use platform that enables trial sponsors and CROs to completely customize eConsent.

  6. Patient-Centric Cardiac Monitoring For Decentralized And Hybrid Trials 5/21/2025

    A patient-centric approach to cardiac monitoring is helping to advance data collection and reliability during decentralized and hybrid clinical trials.

  7. Site Support: The Cornerstone Of The Digital Trial Evolution 5/21/2024

    Follow along as this panel of experts shares key insights from their experiences, highlighting the technologies and processes that lead to successful partnerships in patient-centric digital trials.

  8. On-site ePRO Solutions For Flexible Data Collection Across Devices 3/17/2026

    Optimize flexible electronic patient-reported outcomes that allow participants to switch between site-owned devices, personal hardware, and remote completion.

  9. What It Really Takes To Adopt eConsent Across Large Pharma 3/27/2024

    Explore the benefits of incorporating consent management technology and discover practical strategies for developing effective change management and training programs.

  10. Everything You Need To Know About Adopting eConsent Across Large Pharma Organizations 2/22/2023

    Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.